Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionNanoparticle-formulated recombinant non-replicating adenovirus
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today